Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-015121
Filing Date
2017-08-21
Accepted
2017-08-21 17:15:09
Documents
59
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20170630_10q.htm 10-Q 499884
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 13511
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 13328
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 7396
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6884
  Complete submission text file 0001437749-17-015121.txt   2439036

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS cenb-20170630.xml EX-101.INS 316004
7 EXHIBIT 101.SCH cenb-20170630.xsd EX-101.SCH 43335
8 EXHIBIT 101.CAL cenb-20170630_cal.xml EX-101.CAL 22965
9 EXHIBIT 101.DEF cenb-20170630_def.xml EX-101.DEF 239431
10 EXHIBIT 101.LAB cenb-20170630_lab.xml EX-101.LAB 162003
11 EXHIBIT 101.PRE cenb-20170630_pre.xml EX-101.PRE 254586
Mailing Address 20 N REAR RD LAKESHORE A6 N0R 1A0
Business Address 20 N REAR RD LAKESHORE A6 N0R 1A0 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 171043658
SIC: 2834 Pharmaceutical Preparations